The filing is a routine advance notice of a planned sale by the CEO for personal financial planning. The share count is small relative to total outstanding shares and the CEO's likely total holdings. Monitor the actual Form 4 filing after the sale to confirm execution and remaining stake.
VRTX drugs
VRTX drug pipeline →- ▲ povetacicept 6/10 Filed/PDUFA (BLA under FDA review for accelerated approval in IgAN); Phase 3 (RAINIER in IgAN); Phase 2b/3 (OLYMPUS in p · PDUFA date Nov 30, 2026
- ● inaxaplin 5/10 Phase 2/3
- ▲ ALYFTREK 4/10 Approved
- ● JOURNAVX 4/10 Approved
- ● TRIKAFTA 4/10 Approved
- 6 more · All VRTX drugs, catalysts & trials →
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 6 $547.09entry
- T+1 · 8d ago +0.69%α −1.68% · $550.87
- T+5 · 4d ago −1.55%α −4.15% · $538.60
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Vertex CEO Reshma Kewalramani filed a Form 144 notice of intent to sell 11,866 shares of common stock, with an approximate market value of $6.3 million based on the filing date. The shares were acquired through ESPP purchases and restricted stock vesting between May 2024 and August 2025. This represents a routine insider sale for diversification or tax planning, not a change in fundamental outlook.
Key Facts
- CEO Reshma Kewalramani filed Form 144 on 2026-11-06 to sell 11,866 shares of VRTX common stock.
- Estimated aggregate market value of the proposed sale is $6,307,134.98 based on the filing date price.
- Shares were acquired through ESPP purchases (69 shares on 05/14/2024, 53 shares on 05/14/2025) and restricted stock vesting (1,744 shares on 02/24/2025, 10,000 shares on 08/06/2025).
- The sale is planned for execution on or after 11/06/2026 on Nasdaq.
- The filing is signed by Fidelity Brokerage Services LLC as attorney-in-fact for the CEO.
Financial Impact
Proposed sale of 11,866 shares valued at approximately $6.3 million, representing about 0.0045% of Vertex's $139.2B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur or may be at a different price.
- CEO sales can be misinterpreted by the market as a lack of confidence, though the small size here mitigates that risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007810 |
| Document: 0001959173-26-007810-index.html | 0001959173-26-007810 |
| Document: 0001959173-26-007810.txt | 0001959173-26-007810 |
Track record
21 reports on VRTX
3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +10.87% at T+60 after the Feb 25, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $537.79 Now $531.45 −1.18% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $543.10 Now $531.45 −2.15% settles Nov 23
- Nov 16, 20261d ago 144 Neutral 1/10 Entry $544.98 Now $531.45 −2.48% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $542.00 Now $531.45 −1.95% settles Nov 23
- Nov 12, 20265d ago 144 Neutral 2/10 Entry $542.62 Now $531.45 −2.06% settles Nov 19
- Nov 6, 202611d ago 144 Neutral 2/10 Viewing Entry $547.09 to $538.60 Now $531.45 −2.86% ▼ −1.55% −4.15% vs SPY
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $530.76 to $547.89 Now $531.45 +0.13% ▲ +3.23% +3.81% vs SPY
- Oct 22, 202626d ago 3 Neutral 2/10 Entry $523.93 to $558.88 Now $531.45 +1.44% ▲ +6.67% +7.23% vs SPY
- Oct 20, 202628d ago 8-K Neutral 2/10 Entry $524.52 to $521.03 Now $531.45 +1.32% ▼ −0.67% −0.22% vs SPY
- Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $500.36 to $517.49 Now $531.45 +6.21% ▲ +3.42% +3.57% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers